Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

September 17, 2018

Primary Completion Date

May 31, 2021

Study Completion Date

April 29, 2022

Conditions
Invasive Fungal Infections
Interventions
DRUG

SUBA itraconazole

SUBA itraconazole study drug will consist of two 65 mg capsules to be taken three times a day with food for days 1-3 of study. For days 4-180 of study, two 65mg capsules will be taken twice daily with food.

DRUG

Conventional itraconazole

Conventional itraconazole comparator drug will consist of two 100 mg capsules to be taken three times a day with food for days 1-3 of study. For days 4-180 of study, two 100 mg capsules will be taken twice daily with food.

Trial Locations (12)

35233

University of Alabama at Birmingham, Birmingham

48109

University of Michigan, Ann Arbor

53705

University of Wisconsin, Madison

55455

Unniversity of Minnesota, Minneapolis

60612

Rush University, Chicago

60637

University of Chicago, Chicago

63130

Washington University in St. Louis, St Louis

66211

Metro Infectious Disease Associates, Overland Park

85724

University of Arizona, Tucson

95817

University of California at Davis, Sacramento

27710-1000

Duke University Medical Center, Durham

Unknown

Hospital Santo Tomás, Panama City

All Listed Sponsors
collaborator

University of California, Davis

OTHER

collaborator

Washington University School of Medicine

OTHER

lead

University of Alabama at Birmingham

OTHER

NCT03572049 - Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole | Biotech Hunter | Biotech Hunter